Study Group: Physicians who Treat Migraine Headaches (US)(?)
Council Members in this Study Group: 126
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Neurologist
Medford Neurological Clinic, Inc.
Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...
Director of Neurology
Wesley Headache Clinic
Stephen Landy, MD, is the Director of Neurology at Wesley Headache Clinic and Clinical Professor in Department of Neurology at University of Tennessee. Dr. Landy is certified by the National Board of Medical Examiners, the American Board of Psychiatry and Neurolgy. Also, he is certified by the National...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Neurologists (US) | 1061 |
| Neurologists | 1796 |
| Pain Physicians (US) | 511 |
| Migraine Neurologists (US) | 34 |
| Imitrex Prescribers (US) | 53 |
| Neurologists who Treat Epilepsy (US) | 309 |
| Attending-Level Neurologists at Academic Medical Centers (US) | 549 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
With excellent patient satisfaction, ease of use and excellent cash based reimbursement, there is a rapidly growing aesthetic & skin care business to dermatologic practice. This has clearly impacted access to care by patients with skin disease in my area. Perhaps a better question is...
Extavia, Novartis' brand of interferon beta 1b, has been approved for the treatment of multiple sclerosis by the European Union. With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009. While essentially identical to Bayer's Betaferon interferon beta 1b,...
The data on ABT-089 in adults has been released with positive results, whereas the adolescent/childhood trial is on-going for this novel compound for ADHD. The key difference is the potential to improve learning, not simply regain attention and lessen hyperactivity.
The availability of any existing opioid molecule as a sustained-release preparation, eg Vicodin CR, is an advance in pain management. That being said, however, there is little evidence that the risk of abuse or addiction is less with SR opioids. In fact, the (usually) higher doses is SR...
Copaxone has become the leading treatment for relapsing remitting MS in the US. The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- President
- Medical Director
- Director
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms